| 000 | 01105 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517152317.0 | ||
| 264 | 0 | _c20181009 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1525-0024 | ||
| 024 | 7 |
_a10.1016/j.ymthe.2017.04.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRivière, Isabelle | |
| 245 | 0 | 0 |
_aPerspectives on Manufacturing of High-Quality Cell Therapies. _h[electronic resource] |
| 260 |
_bMolecular therapy : the journal of the American Society of Gene Therapy _c05 2017 |
||
| 300 |
_a1067-1068 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Deaminase _xdeficiency |
| 650 | 0 | 4 |
_aAgammaglobulinemia _xtherapy |
| 650 | 0 | 4 |
_aCell- and Tissue-Based Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSevere Combined Immunodeficiency _xtherapy |
| 700 | 1 | _aRoy, Krishnendu | |
| 773 | 0 |
_tMolecular therapy : the journal of the American Society of Gene Therapy _gvol. 25 _gno. 5 _gp. 1067-1068 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ymthe.2017.04.010 _zAvailable from publisher's website |
| 999 |
_c27132854 _d27132854 |
||